And wherein all amino acids in the D peptide are the D stereoisomeric configuration and said peptide composition is administered in a therapeutically effective dose wherein said composition acts to suppress inflammation underlying the loss of brain function. The D peptide may be esterified, glycosylated, or amidated at E to enhance tissue distribution by promoting egress from the circulation and penetration into the brain.
ORAL ANTI-INFLAMMATORY PEPTIDES TO TREAT EPILEPSY, SEIZURES AND CNS DISORDERS